Clinical Trial Update: A Bioequivalence Study of a New Paracetamol Oral Suspension 24mg/ml Compared to the Marketed Paracetamol Oral Suspension (Panadol Baby and Infant 24mg/ml) in Healthy Adult Subjects [Phase 1]

View source ↗

Summary

Phase 1 bioequivalence study comparing a new paracetamol 24 mg/mL oral suspension to Panadol Baby/Infant 24 mg/mL in healthy adults; study completed with result…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pain

Drugs mentioned

• Panadol Baby and Infant 24 mg/mL paracetamol oral suspension (paracetamol)
• Paracetamol 24 mg/mL oral suspension (new) (paracetamol)

Snippet

Sponsor: HALEON | Conditions: Pain | Phase 1 | Status: COMPLETED | Results posted: 2024-02-20